Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isolagen Therapy for Facial Wrinkles
NCT00654654Phase 2Completed
- Sponsor
- Castle Creek Biosciences
- Start
- Mar 2007
- Primary completion
- Jun 2008
- Modality
- Bone Marrow HSCs, Peripheral Blood HSCs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of azficel-t in rhytides, sponsored by Castle Creek Biosciences. Primary endpoints: Change in Subject Assessment of Wrinkles Compared to Baseline on Subject Wrinkle Assessment and Independent Panel Global Improvement Assessment Compared to Baseline. Started Mar 2007; status: completed.
02
Drugs
azficel-t
03
Conditions
rhytides
Beyond the preview
Go deeper on NCT00654654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654654.